Genetic Technologies Limited (GNTLF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -377.06 Thousand AUD | 98.01% |
| 2023 | -7.31 Million AUD | 33.94% |
| 2022 | -11.07 Million AUD | 46.47% |
| 2021 | -20.69 Million AUD | -50.73% |
| 2020 | -13.73 Million AUD | -544.19% |
| 2019 | -2.13 Million AUD | 61.15% |
| 2018 | -5.48 Million AUD | 50.06% |
| 2017 | -10.98 Million AUD | 1.71% |
| 2016 | -11.17 Million AUD | 38.96% |
| 2015 | -18.31 Million AUD | -5472.35% |
| 2014 | -328.7 Thousand AUD | 80.9% |
| 2013 | -1.72 Million AUD | 80.62% |
| 2012 | -8.88 Million AUD | -76.35% |
| 2011 | -5.03 Million AUD | -72.28% |
| 2010 | -2.92 Million AUD | 68.34% |
| 2009 | -9.23 Million AUD | 26.99% |
| 2008 | -12.64 Million AUD | -12.6% |
| 2007 | -11.23 Million AUD | -19.27% |
| 2006 | -9.41 Million AUD | 44.46% |
| 2005 | -16.95 Million AUD | -59.94% |
| 2004 | -10.6 Million AUD | -81.92% |
| 2003 | -5.82 Million AUD | 18.6% |
| 2002 | -7.16 Million AUD | -1260.52% |
| 2001 | -526.29 Thousand AUD | 57.19% |
| 2000 | -1.22 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -3.64 Million AUD | 50.19% |
| 2024 Q4 | -377.06 Thousand AUD | 0.0% |
| 2024 FY | -145.41 Thousand AUD | 98.01% |
| 2024 Q2 | -3.34 Million AUD | 8.18% |
| 2023 FY | -7.31 Million AUD | 33.94% |
| 2023 Q4 | -7.31 Million AUD | 3.98% |
| 2023 Q3 | -7.62 Million AUD | -71.94% |
| 2023 Q1 | -4.71 Million AUD | 57.43% |
| 2023 Q2 | -4.43 Million AUD | 6.02% |
| 2022 FY | -11.07 Million AUD | 46.47% |
| 2022 Q3 | -11.34 Million AUD | 15.31% |
| 2022 Q4 | -11.07 Million AUD | 2.33% |
| 2022 Q2 | -13.39 Million AUD | 0.59% |
| 2022 Q1 | -13.47 Million AUD | 34.9% |
| 2021 Q4 | -20.69 Million AUD | 0.86% |
| 2021 Q2 | -16.06 Million AUD | 1.54% |
| 2021 Q1 | -16.31 Million AUD | -18.83% |
| 2021 FY | -20.69 Million AUD | -50.73% |
| 2021 Q3 | -20.87 Million AUD | -29.93% |
| 2020 Q4 | -13.73 Million AUD | 1.72% |
| 2020 Q1 | -3.13 Million AUD | -47.29% |
| 2020 Q2 | -2.91 Million AUD | 7.16% |
| 2020 Q3 | -13.97 Million AUD | -379.36% |
| 2020 FY | -13.73 Million AUD | -544.19% |
| 2019 FY | -2.13 Million AUD | 61.15% |
| 2019 Q2 | -3.23 Million AUD | 0.0% |
| 2019 Q1 | -3.23 Million AUD | 41.05% |
| 2019 Q3 | -2.13 Million AUD | 34.1% |
| 2019 Q4 | -2.13 Million AUD | 0.0% |
| 2018 Q1 | -7.59 Million AUD | 30.89% |
| 2018 Q4 | -5.48 Million AUD | 0.0% |
| 2018 Q3 | -5.48 Million AUD | 27.74% |
| 2018 FY | -5.48 Million AUD | 50.06% |
| 2018 Q2 | -7.59 Million AUD | 0.0% |
| 2017 Q4 | -10.98 Million AUD | 0.0% |
| 2017 Q3 | -10.98 Million AUD | 26.75% |
| 2017 Q2 | -15 Million AUD | 0.0% |
| 2017 Q1 | -15 Million AUD | -34.19% |
| 2017 FY | -10.98 Million AUD | 1.71% |
| 2016 Q4 | -11.17 Million AUD | 0.0% |
| 2016 Q3 | -11.17 Million AUD | 23.0% |
| 2016 Q2 | -14.51 Million AUD | 0.0% |
| 2016 Q1 | -14.51 Million AUD | 20.73% |
| 2016 FY | -11.17 Million AUD | 38.96% |
| 2015 Q1 | 225.19 Thousand AUD | 168.51% |
| 2015 Q3 | -18.31 Million AUD | -8233.66% |
| 2015 Q2 | 225.19 Thousand AUD | 0.0% |
| 2015 FY | -18.31 Million AUD | -5472.35% |
| 2015 Q4 | -18.31 Million AUD | 0.0% |
| 2014 Q2 | -2.86 Million AUD | 0.0% |
| 2014 Q1 | -2.86 Million AUD | -66.37% |
| 2014 Q4 | -328.7 Thousand AUD | 0.0% |
| 2014 Q3 | -328.7 Thousand AUD | 88.52% |
| 2014 FY | -328.7 Thousand AUD | 80.9% |
| 2013 Q3 | -1.72 Million AUD | 71.02% |
| 2013 FY | -1.72 Million AUD | 80.62% |
| 2013 Q4 | -1.72 Million AUD | 0.0% |
| 2013 Q2 | -5.94 Million AUD | 0.0% |
| 2012 Q2 | -12.54 Million AUD | 0.0% |
| 2012 FY | -8.88 Million AUD | -76.35% |
| 2012 Q4 | -8.88 Million AUD | 0.0% |
| 2011 FY | -5.03 Million AUD | -72.28% |
| 2011 Q4 | -5.03 Million AUD | 0.0% |
| 2011 Q2 | -8.16 Million AUD | 0.0% |
| 2010 Q2 | -5.06 Million AUD | 0.0% |
| 2010 FY | -2.92 Million AUD | 68.34% |
| 2010 Q4 | -2.92 Million AUD | 0.0% |
| 2009 FY | -9.23 Million AUD | 26.99% |
| 2009 Q2 | -10.28 Million AUD | 0.0% |
| 2009 Q4 | -7.45 Million AUD | 0.0% |
| 2008 FY | -12.64 Million AUD | -12.6% |
| 2008 Q2 | -13.6 Million AUD | 0.0% |
| 2008 Q4 | -12.64 Million AUD | 0.0% |
| 2007 FY | -11.23 Million AUD | -19.27% |
| 2007 Q4 | -11.23 Million AUD | 0.0% |
| 2007 Q2 | -8.74 Million AUD | 0.0% |
| 2006 FY | -9.41 Million AUD | 44.46% |
| 2006 Q4 | -9.41 Million AUD | 0.0% |
| 2006 Q2 | -15.71 Million AUD | 0.0% |
| 2005 Q2 | -10.16 Million AUD | 0.0% |
| 2005 Q4 | -16.95 Million AUD | 0.0% |
| 2005 FY | -16.95 Million AUD | -59.94% |
| 2004 FY | -10.6 Million AUD | -81.92% |
| 2003 FY | -5.82 Million AUD | 18.6% |
| 2002 FY | -7.16 Million AUD | -1260.52% |
| 2001 FY | -526.29 Thousand AUD | 57.19% |
| 2000 FY | -1.22 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | 117.093% |
| Arrayit Corporation | 1.05 Million USD | 135.721% |
| Atlantic International Corp. | 236.49 Thousand USD | 259.437% |
| Biocept, Inc. | -788 Thousand USD | 52.149% |
| Bioqual, Inc. | -12 Million USD | 96.86% |
| CardioGenics Holdings Inc | 22.73 Thousand USD | 1758.217% |
| DermTech, Inc. | 17.65 Million USD | 102.136% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 99.934% |
| HTG Molecular Diagnostics, Inc. | -7.37 Million USD | 94.889% |
| iMD Companies, Inc. | 1.11 Million USD | 133.79% |
| IDenta Corp. | 524.85 Thousand USD | 171.842% |
| Interpace Biosciences, Inc. | 7.69 Million USD | 104.901% |
| Integrative Health Technologies, Inc. | -26.95 Thousand USD | -1299.013% |
| InVitro International | -313.14 Thousand USD | -20.412% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | 124.079% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | -52783.871% |
| Medical Imaging Corp. | 3.79 Million USD | 109.946% |
| NovelStem International Corp. | 3.52 Million USD | 110.707% |
| Optigenex Inc. | 8.93 Million USD | 104.221% |
| PharmChem, Inc. | -1.49 Million USD | 74.769% |
| Proteome Sciences plc | 14.57 Million USD | 102.587% |
| Response Genetics, Inc | -13.08 Million USD | 97.119% |
| Rennova Health, Inc. | 14.82 Million USD | 102.543% |
| RushNet, Inc. | 4.8 Million USD | 107.854% |
| ScreenPro Security Inc. | 135.58 Thousand USD | 378.092% |
| Stella Diagnostics Inc. | 6.19 Million USD | 106.088% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | 121.131% |
| Todos Medical Ltd. | 38.31 Million USD | 100.984% |